Schedule 13G ownership disclosure
ACTINIUM PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00507W206
Event date: 2020-08-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-20-002152
- Form type
- SC 13G
- Filer
- Actinium Pharmaceuticals, Inc.
- CIK
- CIK 1388320
- Filed
- Aug 12, 2020
- Reporting period
- Aug 05, 2020
- Description
- Schedule 13G beneficial ownership